Kathryn J Jacob1, Vita Sonjak1, Sally Spendiff2, Russell T Hepple3, Stéphanie Chevalier1,4,5, Anna Perez1, José A Morais1,4,5. 1. Research Institute of the McGill University Health Center, Montreal, QC, Canada. 2. Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada. 3. Department of Physical Therapy, Department of Physiology & Functional Genomics, University of Florida, Gainesville, FL, United States. 4. Division of Geriatric Medicine, MUHC-Montreal General Hospital, McGill University, Montreal, QC, Canada. 5. School of Human Nutrition, McGill University, Montreal, QC, Canada.
Abstract
Background: Frailty is a clinical condition associated with loss of muscle mass and strength (sarcopenia). Mitochondria are centrally implicated in frailty and sarcopenia. Leucine (Leu) can alter mitochondrial content in myocytes, while resistance training (RT) is the strongest stimulus to counteract sarcopenia and may enhance mitochondrial biogenesis. Objective: We determined the effects of Leu supplementation and RT on mitochondrial content and function in pre/frail elderly women in a randomized double-blinded placebo-controlled study. Methods:Nineteen pre/frail elderly women (77.5 ± 1.3 y, BMI: 25.1 ± 0.9 kg/m2), based on the Frailty Phenotype, underwent 3-months of RT 3×/week with protein-optimized diet and were randomized to 7.5 g/d of Leu supplementation or placebo alanine (Ala). Pre/post-intervention mitochondrial respiration, reactive oxygen species (ROS) production, calcium retention capacity (CRC), time to permeability transition pore (mPTP) opening, mitochondrial voltage-dependent anion channel (VDAC) protein content, leg press1-repetition maximum (1RM), and 6-min walk test (6MWT) were measured. Results:No time, supplementation, or interaction effects were observed for respiration, ROS, time to mPTP opening, and CRC. VDAC levels significantly increased in the Leu group post-intervention (p = 0.012). Both groups significantly increased leg press 1RM and 6MWT, with no effect of supplementation. Discussion: Leu supplementation with 3 months of RT increased mitochondrial content. Future studies should investigate if there is an increase in mitochondrial turnover or a shift in quality control (mitophagy) in leucine supplemented pre/frail elderly women who undergo 12 weeks of RT. Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT01922167.
RCT Entities:
Background: Frailty is a clinical condition associated with loss of muscle mass and strength (sarcopenia). Mitochondria are centrally implicated in frailty and sarcopenia. Leucine (Leu) can alter mitochondrial content in myocytes, while resistance training (RT) is the strongest stimulus to counteract sarcopenia and may enhance mitochondrial biogenesis. Objective: We determined the effects of Leu supplementation and RT on mitochondrial content and function in pre/frail elderly women in a randomized double-blinded placebo-controlled study. Methods: Nineteen pre/frail elderly women (77.5 ± 1.3 y, BMI: 25.1 ± 0.9 kg/m2), based on the Frailty Phenotype, underwent 3-months of RT 3×/week with protein-optimized diet and were randomized to 7.5 g/d of Leu supplementation or placebo alanine (Ala). Pre/post-intervention mitochondrial respiration, reactive oxygen species (ROS) production, calcium retention capacity (CRC), time to permeability transition pore (mPTP) opening, mitochondrial voltage-dependent anion channel (VDAC) protein content, leg press 1-repetition maximum (1RM), and 6-min walk test (6MWT) were measured. Results: No time, supplementation, or interaction effects were observed for respiration, ROS, time to mPTP opening, and CRC. VDAC levels significantly increased in the Leu group post-intervention (p = 0.012). Both groups significantly increased leg press 1RM and 6MWT, with no effect of supplementation. Discussion: Leu supplementation with 3 months of RT increased mitochondrial content. Future studies should investigate if there is an increase in mitochondrial turnover or a shift in quality control (mitophagy) in leucine supplemented pre/frail elderly women who undergo 12 weeks of RT. Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT01922167.
Authors: Anna-Maria Joseph; Peter J Adhihetty; Thomas W Buford; Stephanie E Wohlgemuth; Hazel A Lees; Linda M-D Nguyen; Juan M Aranda; Bhanu D Sandesara; Marco Pahor; Todd M Manini; Emanuele Marzetti; Christiaan Leeuwenburgh Journal: Aging Cell Date: 2012-07-09 Impact factor: 9.304
Authors: Thomas G Manfredi; Michael A Monteiro; Linda S Lamont; Maria F Singh; Mona Foldvari; Sebrina White; Arthur C Cosmas; Maria L Urso Journal: J Strength Cond Res Date: 2013-02 Impact factor: 3.775
Authors: Roger A Vaughan; Randi Garcia-Smith; Nicholas P Gannon; Marco Bisoffi; Kristina A Trujillo; Carole A Conn Journal: Amino Acids Date: 2013-06-29 Impact factor: 3.520
Authors: Martin Gram; Andreas Vigelsø; Takashi Yokota; Christina Neigaard Hansen; Jørn Wulff Helge; Martin Hey-Mogensen; Flemming Dela Journal: Exp Gerontol Date: 2014-09-02 Impact factor: 4.032
Authors: Kyle D Flack; Brenda M Davy; Martin DeBerardinis; Nabil E Boutagy; Ryan P McMillan; Matthew W Hulver; Madlyn I Frisard; Angela S Anderson; Jyoti Savla; Kevin P Davy Journal: Physiol Rep Date: 2016-07
Authors: Giovanna Distefano; Robert A Standley; Xiaolei Zhang; Elvis A Carnero; Fanchao Yi; Heather H Cornnell; Paul M Coen Journal: J Cachexia Sarcopenia Muscle Date: 2018-01-24 Impact factor: 12.910
Authors: Andreas M Fritzen; Frank B Thøgersen; Kasper Thybo; Christoffer R Vissing; Thomas O Krag; Cristina Ruiz-Ruiz; Lotte Risom; Flemming Wibrand; Louise D Høeg; Bente Kiens; Morten Duno; John Vissing; Tina D Jeppesen Journal: Cells Date: 2019-03-12 Impact factor: 6.600